Olmesartan Medoxomil + Aliskiren Interaction
Contraindicatedinteraction on record
Description
Co-administration contraindicated in patients with diabetes. Avoid in patients with renal impairment (GFR <60 ml/min). Associated with increased risks of hypotension, hyperkalemia, and acute renal failure.
Mechanism
Dual RAS blockade increasing hypotension, hyperkalemia, and renal dysfunction risk
Source: NLP:olmesartan medoxomil